Caldox 200 IU Nasal Spray 30 MDI

Caldox 200 IU Nasal Spray 30 MDI is primarily indicated for the treatment of postmenopausal osteoporosis in women more than five years postmenopause when alternative therapies are unsuitable. Post-menopausal osteoporosis is a medical condition that causes thinning and weakening of the bones during/after a menopausal period.

Caldox 200 IU Nasal Spray 30 MDI contains Calcitonin, a human hormone that prevents bone breakdown and increases bone density (thickness). Thus, it helps treat osteoporosis in postmenopausal women.

Use Caldox 200 IU Nasal Spray 30 MDI as prescribed by the doctor. Caldox 200 IU Nasal Spray 30 MDI may cause certain side effects such as hypocalcemia, runny nose, nosebleed, sinus pain, application site reactions such as rhinitis (stuffy nose), epistaxis (nose bleeds) and other nasal symptoms, back pain, arthralgia (Joint pain) and headache. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.

Caldox 200 IU Nasal Spray 30 MDI is for intranasal use only; do not inject or take it orally. Before using Caldox 200 IU Nasal Spray 30 MDI, inform your doctor of all your medical conditions, sensitivities, and medications. Caldox 200 IU Nasal Spray 30 MDI is intended for post-menopausal women; therefore, it should not be recommended for other populations. Avoid drinking alcohol because it affects how the body absorbs calcium and vitamin D, which are essential for good bone formation.

Caldox 200 IU Nasal Spray 30 MDI is used in the treatment of Postmenopausal osteoporosis. The detailed uses of Caldox 200 IU Nasal Spray 30 MDI are as follows:

• Treat postmenopausal osteoporosis: Caldox 200 IU Nasal Spray 30 MDI helps slow bone loss and increase bone density in women who are at least five years past menopause. It reduces the risk of vertebral fractures by mimicking the natural hormone calcitonin, which regulates calcium levels and inhibits bone breakdown.
• Manage bone pain in Paget’s disease: Caldox 200 IU Nasal Spray 30 MDI alleviates bone discomfort associated with abnormal bone remodeling in Paget’s disease by suppressing osteoclast activity and stabilizing bone turnover.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safety.
• Remove the cap of the bottle, insert the tip into a nostril while closing the other nostril, and spray towards the sides of the nostril. Keep your head straight and breathe gently. Repeat the same process for another nostril.
• Wipe the nozzle with a clean tissue and replace the cap after each use.

Caldox 200 IU Nasal Spray 30 MDI contains Calcitonin, a calcitonin receptor agonist that prevents the loss of bones that happens after menopause and helps to rebuild bones. Calcitonin is a hormone that the C-cells in the thyroid gland produce and release. It opposes the parathyroid hormone's action, helping regulate the blood’s calcium and phosphate levels. Caldox 200 IU Nasal Spray 30 MDI works by suppressing the activity of the osteoclasts (cells that break down bone). When the osteoclasts break down bone tissue, the calcium enters the bloodstream. Caldox 200 IU Nasal Spray 30 MDI lessens the amount of calcium in the blood by preventing the breakdown of bone. Thereby, Caldox 200 IU Nasal Spray 30 MDI strengthens the bones and minimizes the risk of fractures. Caldox 200 IU Nasal Spray 30 MDI also seems to decrease the amount of calcium the kidneys can re-absorb, lowering calcium levels further.

Before using Caldox 200 IU Nasal Spray 30 MDI, Inform your doctor about all your medical conditions, sensitivities, and all medications you are using. Caldox 200 IU Nasal Spray 30 MDI is intended for post-menopausal women; therefore, Caldox 200 IU Nasal Spray 30 MDI should not be recommended for other populations. In rare situations, individuals using Caldox 200 IU Nasal Spray 30 MDI may be affected with anaphylactic shock (a sudden, severe, life-threatening allergic reaction leading to difficulty breathing); if you encounter it, stop using Caldox 200 IU Nasal Spray 30 MDI and contact your doctor immediately.